GlassScriptPhysician profile
Bradley Tun
NPI 1881125748
$2,153.30
in general payments reported to CMS, 2019-2025
17 companies · $74.76 in 2025
The $74.76 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $391 · 2021: $717 · 2022: $468 · 2023: $407 · 2024: $96.03 · 2025: $74.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $583.26 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $414.21 | 2020-2023 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $205.95 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $150.00 | 2022 | |
| Pfizer INC. | $148.29 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.67 | 2020-2022 | |
| Abiomed | $117.64 | 2021-2023 | Impella |
| Abbott Laboratories | $101.00 | 2023 | Diamondback Coronary |
| Irhythm Technologies, INC. | $62.79 | 2024 | Zio Monitor, Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $41.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.24 | 2024 | Jardiance |
| Philips North America LLC | $32.41 | 2025 | Extended Holter |
| Lantheus Medical Imaging, INC. | $31.39 | 2022 | |
| Angiodynamics, INC. | $30.45 | 2021 | |
| Boston Scientific Corporation | $25.56 | 2025 | Bodyguardian |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $18.69 | 2022 | |
| Baxter Healthcare | $16.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Tun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.